UBS AM’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $418M | Sell |
|
|||||
|
2025
Q2 | $452M | Sell |
|
|||||
|
2025
Q1 | $596M | Sell |
|
|||||
|
2024
Q4 | $700M | Buy |
|
|||||
|
2024
Q3 | $794M | Sell |
|
|||||
|
2024
Q2 | $891M | Buy |
|
|||||
|
2024
Q1 | $659M | Buy |
|
|||||
|
2023
Q4 | $585M | Sell |
|
|||||
|
2023
Q3 | $572M | Buy |
|
|||||
|
2023
Q2 | $547M | Hold |
|
|||||
|
2023
Q1 | $547M | Buy |
|
|||||
|
2022
Q4 | $438M | Buy |
|
|||||
|
2022
Q3 | $414M | Sell |
|
|||||
|
2022
Q2 | $357M | Buy |
|
|||||
|
2022
Q1 | $402M | Sell |
|
|||||
|
2021
Q4 | $384M | Buy |
|
|||||
|
2021
Q3 | $317M | Sell |
|
|||||
|
2021
Q2 | $320M | Sell |
|
|||||
|
2021
Q1 | $293M | Sell |
|
|||||
|
2020
Q4 | $311M | Buy |
|
|||||
|
2020
Q3 | $332M | Buy |
|
|||||
|
2020
Q2 | $313M | Buy |
|
|||||
|
2020
Q1 | $163M | Buy |
|
|||||
|
2019
Q4 | $124M | Sell |
|
|||||
|
2019
Q3 | $92.6M | Sell |
|
|||||
|
2019
Q2 | $128M | Sell |
|
|||||
|
2019
Q1 | $168M | Buy |
|
|||||
|
2018
Q4 | $121M | Buy |
|
|||||
|
2018
Q3 | $129M | Sell |
|
|||||
|
2018
Q2 | $117M | Sell |
|
|||||
|
2018
Q1 | $117M | Sell |
|
|||||
|
2017
Q4 | $208M | Buy |
|
|||||
|
2017
Q3 | $128M | Sell |
|
|||||
|
2017
Q2 | $144M | Buy |
|
|||||
|
2017
Q1 | $112M | Sell |
|
|||||
|
2016
Q4 | $120M | Sell |
|
|||||
|
2016
Q3 | $135M | Sell |
|
|||||
|
2016
Q2 | $171M | Buy |
|
|||||
|
2016
Q1 | $171M | Buy |
|
|||||
|
2015
Q4 | $234M | Sell |
|
|||||
|
2015
Q3 | $203M | Sell |
|
|||||
|
2015
Q2 | $392M | Sell |
|
|||||
|
2015
Q1 | $399M | Sell |
|
|||||
|
2014
Q4 | $384M | Sell |
|
|||||
|
2014
Q3 | $396M | Sell |
|
|||||
|
2014
Q2 | $321M | Buy |
|
|||||
|
2014
Q1 | $330M | Buy |
|
|||||
|
2013
Q4 | $279M | Buy |
|
|||||
|
2013
Q3 | $113M | Buy |
|
|||||
|
2013
Q2 | $79.4M | Buy |
|